Bio & Healthcare

Omics analysis, medical image analysis, compound analysis using deep learning

Overview

PFN focuses on omics analysis, medical image analysis, and compound analysis using deep learning.

Aiming to bring new blood tests based for early cancer detection, we established PFDeNA, Inc. (a joint venture with DeNA, Inc.) in Japan in July 2016, and Preferred Medicine, Inc.(a joint venture with Mitsui & Co., Ltd.) in the United States in November 2018.

Features

Early cancer detection system from a small amount of blood

Kaggle: Achieved 6th place out of 1445 teams for the Pneumonia Detection Challenge

Achieved IPAB Award in the 4th IT Drug Discovery Contest

Other Projects

Contact

Contact us here.